Publications

5539 Results

Five year follow-up of INT C9741: dose-dense (DD) chemotherapy (CRx) is safe and effective.

Authors
C Hudis;M Citron;D Berry;C Cirrincione;W Gradishar;N Davidson;S Martino;R Livingston;J Ingle;E Perez;J Abrams;R Schilsky;M Ellis;H Muss;L Norton;E Winer
Journal / Conference
Breast Cancer Research and Treatment 94(Suppl 1):S20-S21(#41)
Year
2005
Research Committee(s)
Breast
Study Number(s)
C9741

A phase II trial of BAY 43-9006 in patients with recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). a Southwest Oncology Group (SWOG) trial

Authors
S Williamson;J Moon;C Huang;G Wolf;S Urba
Journal / Conference
European Journal of Cancer Supplements 3(2):286 (#995)
Year
2005
Research Committee(s)
Head and Neck
Study Number(s)
S0420

Ixabepilone (epothilone b analogue BMS-247550) is active in chemotherapy-naive patients with hormone-refractory prostate cancer: a Southwest Oncology Group trial S0111

Authors
M Hussain;CM Tangen;PN Lara;UN Vaishampayan;DP Petrylak;AD Colevas;WA Sakr;ED Crawford
Journal / Conference
Journal of Clinical Oncology 23(34):8724-8729
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
S0111

Meta-analysis to evaluate the role of interferon in follicular lymphoma.

Authors
AZS Rohatiner;WM Gregory;B Peterson;E Borden;P Solal-Celigny;A Hagenbeek;RI Fisher;M Unterhalt;R Arranz;T Chisesi;A Aviles;TA Lister
Journal / Conference
Journal of Clinical Oncology 23(10):2215-2223
Year
2005
Research Committee(s)
Lymphoma

Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.

Authors
EA Klein;CM Tangen;PJ Goodman;SM Lippman;IM Thompson
Journal / Conference
Journal of Clinical Oncology 23(30):7460-7466
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Erectile dysfunction and subsequent cardiovascular disease

Authors
IM Thompson;CM Tangen;P Goodman;JL Probstfield;CM Moinpour;CA Coltman
Journal / Conference
JAMA 294(23):2996-3002
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Phase III randomized study of adjuvant radiation therapy versus observation in patients with pathologic T3 prostate cancer (SWOG 8794)

Authors
G Swanson;I Thompson;C Tangen;G Miller;MS Lucia;D Troyer;J Paradelo;J Chin;E Messing;E Canby-Hagino;J Forman;ED Crawford
Journal / Conference
Proc ASTRO, Int J Radiat Oncol Biol Phy 63 (Suppl 1):S1 (#1), 2005.
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Mantle cell lymphoma: at last, some hope for successful innovative treatment strategies

Authors
RI Fisher
Journal / Conference
Journal of Clinical Oncology 23(4):657-658
Year
2005
Research Committee(s)
Lymphoma

Behavior and cancer prevention

Authors
CC Gotay
Journal / Conference
Journal of Clinical Oncology 23(2):301-310
Year
2005
Research Committee(s)
Cancer Control

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

Authors
S Bea;A Zettl;G Wright;I Salaverria;P Jehn;V Moreno;C Burek;G Ott;X Puig;L Yang;A Lopez-Guillermo;WC Chan;TC Greiner;DD Weisenburger;JO Armitage;RD Gascoyne;JM Connors;TM Grogan;R Braziel;RI Fisher;EB Smeland;S Kvaloy;H Holte;J Delabie;R Simon;J Powell;WH Wilson;ES Jaffe;E Montserrat;HK Muller Hermelink;LM Staudt;E Campo;A Rosenwald
Journal / Conference
Blood 106(9):3183-3190
Year
2005
Research Committee(s)
Lymphoma